16
Paris, 4th November 2011 S i l U dt S i l U dt Surgical Updates Surgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK

t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Paris, 4th November 2011

S i l U d tS i l U d tSurgical UpdatesSurgical Updates

Riccardo A Audisio, MD, FRCSUniversity of Liverpool - UK

Page 2: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

treatment goals for older patients

Maximize/maintain potential life span

Maintain dignity of life, maximize self-esteem

Maximize independent function, minimize dependence

Relieve suffering (pain)Relieve suffering (pain)

When cure is not be possible palliation/comfort When cure is not be possible, palliation/comfort are just as important

Page 3: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

CRC Oldest Olds & Surgical Risk 9,070 surgical pts >70yrs (4,162 >80yrs)

higher dependency, ASA, comorbidity ratelower albumin, drinking/smoking habit

longer hospital staymore minor & major post-op. complications

more operative deathsmore operative deaths

Page 4: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Pancreatic cancer - SEER 1992-2005Medicare >66yrs: 9 553ptsMedicare >66yrs: 9,553pts

20 29 0 1/100 00020-29yrs: 0,1/100,000>80yrs: 87.2/100,000

increasing age ~ less surgeryg g g y81%<70yrs vs 45%>85yrs

even for patients with no comorbidities

11% increase in resection rate/yeary

Page 5: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

operative mortality is decreasing2-yr survival rates:resected 35%35%unresected 7%

“it is important pts understand it is important pts understand the risk of mortality as well asythe significant advantage of

surgical resection”

Page 6: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Impact of age on decision making for liver surgeryECOG not varying with age (p=0.08)for liver surgeryECOG not varying with age (p 0.08)

Page 7: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

% patient’s preference to physician’s f f i d ith preference for surgery increased with age

(29% vs 50%)

Page 8: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Retrospective study 220 pts; 75>yrs receiving Radical Cystectomy

Developed a nomogram that provides i di id li d i k t f 90 d i lindividualised risk-esteem of 90-day survival

Mortality rate is high (10-15%) in this group y g ( ) g pand the nomogram allows offering

individualised treatment

Albumin is a strong predictor of post-Albumin is a strong predictor of post-operative mortality

Page 9: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

CardioPulmonary Exercise Testing (CPE )(CPEx)

Formal assessment of maximum oxygen Formal assessment of maximum oxygen consumption during exercise (VO2 max)

Cohort studies and a meta-analysis report the association of low VO2 max and ‘high the association of low VO2 max and high risk’ lung resection

Studies are under-powered: mortality rate for lobectomy averages 2% (largest study

Anaesthesia TF @ SIOGon 422pts had 15 deaths)

Page 10: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

CPEx68 ‘very high risk’ patients (FEV1 <900 ml and VO2 max <15/ml/kg/min) operated: / / g/ ) p1pt died (30 days) + 3pts died (in hosp)

These operated patients had more than double the median survival compared pwith the non-operated patients (36.0 months vs 15.8 months, p<0.001)p )

Denying patients with ‘prohibitive risk’ y g p pmay be against their best interests

Anaesthesia TF @ SIOG

Page 11: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

risk prediction & decision making processfor SURGICAL patients:for SURGICAL patients:

CGAvs

GFI - VES13 - TUG

>300 patients entered

median age 76yrs

tests are predictive - some is better…

Page 12: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

quick screening tools in clinical practice

slow gait speed confers 2-3 fold increase mortality or major morbidityincrease mortality or major morbidity

Page 13: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

69pts >70yrs High-grade prostate ca. treated with robotic radical prostatectomy

operative time: 175 minutes (IQR: 136.8 –202.5)

bl d l 150 (IQR 100 200)blood loss: 150cc (IQR: 100–200)

4 complications (5.8%): 2 leaks and 2 ileus

postoperative stay: 1day (all pts<3 days)

biochemical recurrence: 12pts (17.4%)

biochemical DFS: 91% at 12mos (86% at 36mos)

good functional outcomes at 26.2mosRobotic RP safe and feasible

Good oncologic/functional outcomes

g

Good oncologic/functional outcomesChronological age not a contraindication

Page 14: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

SEER (2001-2005)17 638pts >66yrs stage I-II NSCLC 17,638pts >66yrs stage I-II NSCLC

to compare areas of high vs low rates of curative surgerycurative surgery

High rates Low rates

resection rates 79% 63%

1 yr mortality 18% 23%1-yr mortality 18% 23%

1-yr cancer 12% 17%

Higher rates of surgery associate to improved i l

mortality

survivalNeed to identify and reduce barriers to surgery

Page 15: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Tailored TreatmentTailored Treatment

Neoadjuvant chemo-RT offers an excellent i d f t it t thi window of opportunity to this purpose

PRE-ABILITATION: correction of anemia, dehydration, malnourishment, depression…

Optimized patient’s conditions, as p p ,highlighted by frailty assessment tools, to

reduce complications, mortality & hospital p , y pstay

Page 16: t Ud SilS urgical Updatest Ud SilS urgical Updates Riccardo A Audisio, MD, FRCS University of Liverpool - UK treatment goals for older patients Maximize/maintain potential life span

Surgery in the Elderly